This page shows you your search results in order of relevance. This is page number 16.
Order by Relevance | Date
Total 442 results found since Jan 2013.
Utilization of the Track Embolization Technique to Improve the Safety of Percutaneous Lung Biopsy and/or Fiducial Marker Placement
To describe and present outcomes of the track embolization technique with absorbable hemostat-gelatin-powder during percutaneous CT-guided lung biopsy and/or fiducial marker placement versus the standard of care (no track embolization) in an attempt to decrease rates of pneumothorax (PTX), chest tube placement, hemorrhage and/or complications, and average cost-per patient.
Source: Clinical Imaging - June 16, 2016 Category: Radiology Authors: Amanjit S. Baadh, Jason C. Hoffmann, Ahmed Fadl, Dipan Danda, Vijay R. Bhat, Nicholas Georgiou, Man Hon Source Type: research
Evaluation of Lymphorrhea and Incidence of Lymphoceles: 4DryField® PH in Radical Retropubic Prostatectomy.
Conclusion. Application of 4DF on lymph node dissection areas lessened total drain loss and significantly lowered high volume drain loss. Furthermore, 4DF reduced frequency of late lymphoceles and lymphoceles requiring treatment by half, as well as duration of percutaneous drainage by more than two-thirds.
PMID: 27418927 [PubMed]
Source: Advances in Urology - July 16, 2016 Category: Urology & Nephrology Tags: Adv Urol Source Type: research
Hydrophobically-Modified Chitosan Gauze: A Novel Topical Hemostat
Currently, the standard of care for treating severe hemorrhage in a military setting is Combat GauzeTM (CG). Previous work has shown that hydrophobically modified chitosan (hm-C) has significant hemostatic capability relative to its native chitosan counterpart. This work aims to evaluate gauze coated in hm-C relative to CG as well as ChitoGauze ® (ChG) in a lethal in vivo hemorrhage model.
Source: Journal of Surgical Research - July 26, 2016 Category: Surgery Authors: Apurva Chaturvedi, Matthew B. Dowling, John P. Gustin, Thomas M. Scalea, Srinivasa R. Raghavan, Jason D. Pasley, Mayur Narayan Source Type: research
Hydrophobically modified chitosan gauze: a novel topical hemostat
Currently, the standard of care for treating severe hemorrhage in a military setting is Combat Gauze (CG). Previous work has shown that hydrophobically modified chitosan (hm-C) has significant hemostatic capability relative to its native chitosan counterpart. This work aims to evaluate gauze coated in hm-C relative to CG as well as ChitoGauze (ChG) in a lethal in vivo hemorrhage model.
Source: Journal of Surgical Research - July 26, 2016 Category: Surgery Authors: Apurva Chaturvedi, Matthew B. Dowling, John P. Gustin, Thomas M. Scalea, Srinivasa R. Raghavan, Jason D. Pasley, Mayur Narayan Source Type: research
Nociceptive and Neuronal Evaluation of the Sciatic Nerve of Wistar Rats Subjected to Compression Injury and Treated with Resistive Exercise.
Conclusion. Climb stairs resistance exercise was not effective to speed up the regenerative process of axons.
PMID: 27594795 [PubMed - in process]
Source: Pain Research and Management - September 8, 2016 Category: Anesthesiology Authors: Antunes JS, Lovison K, Karvat J, Peretti AL, Vieira L, Higuchi GH, Brancalhão RM, Ribeiro Lde F, Bertolini GR Tags: Pain Res Manag Source Type: research
A standardized surgical technique for removal of the Interstim tined lead.
CONCLUSION: Permanent tined leads can break on removal and retained fragments can pose significant health consequences. Our technique standardizes the approach for removal and is safe and effective in our series.
PMID: 27705733 [PubMed - in process]
Source: Canadian Journal of Urology - October 10, 2016 Category: Urology & Nephrology Tags: Can J Urol Source Type: research
Johnson & Johnson ’ s Ethicon wins FDA nod for expanded Evarrest indication
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon said today it won an expanded indication from the FDA for its Evarrest fibrin sealant patch, now cleared for use as an adjunctive hemostat across a “broad range” of challenging patient types and surgical situations.
The company touted the win as a significant milestone in controlling problematic bleeding situations “with high confidence.”
“I’m usually very conservative when using new products but I think Evarrest stands out as one of those products that has made a difference in our practice. I’ve used Evarrest to manage troubl...
Source: Mass Device - October 25, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Blood Management Food & Drug Administration (FDA) Regulatory/Compliance Surgical Ethicon Johnson & Johnson Source Type: news
Hemostatic Efficacy of Nanofibrous Matrix in Rat Liver Injury Model.
Abstract
This present study examined the hemostatic efficacy of nanofibrous matrix in a rat liver model. The nanofibrous matrix comprising gelatin and polycaprolactone was prepared by electrospinning method. Twelve animals underwent surgery and were followed-up for a month. Time taken to cease bleeding, activated partial thromboplastin time, prothrombin time, and fibrinogen concentration were measured. Histopathological examination of liver was also done of treated and control animals. All test animals showed very rapid hemostasis after application of electrospun sheet. Histopathological study showed quick recover...
Source: Surgical Innovation - October 25, 2016 Category: Surgery Authors: Jaiswal AK, Chhabra H, Narwane S, Rege N, Bellare JR Tags: Surg Innov Source Type: research
J & J ’ s Evarrest fibrin sealant patch wins expanded indication for hemostasis
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon said today that the FDA approved an expanded indication for its Evarrest fibrin sealant patch as an supplementary hemostat.
With the expanded indication, the patch can be used with manual compression as an adjunct to hemostasis in adult surgery patients, when standard surgical techniques to control bleeding such as suture or ligature are ineffective. The fibrin sealant patch uses biologics to rapidly stop problematic bleeding while a patient is undergoing surgery. The drug device reacts human thrombin and fibrinogen to form a fibrin clot, providing a structure for clot f...
Source: Mass Device - December 2, 2016 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Regulatory/Clearance Surgical Ethicon Johnson & Johnson Source Type: news
Nano-hemostats and a Pilot Study of Their Use in a Large Animal Model of Major Vessel Hemorrhage in Endoscopic Skull Base Surgery
We present a summary of the clinical studies to date and a small pilot study of nano-hemostat in an endoscopic sheep model of major vessel hemorrhage to determine its efficacy in stopping bleeding in this potentially catastrophic complication. [...] Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents | Abstract | Full text
Source: Journal of Neurological Surgery Part B: Skull Base - December 11, 2016 Category: Neurosurgery Authors: Jukes, Alistair Murphy, Jae Vreugde, Sarah Psaltis, Alkis Wormald, P. J. Tags: Original Article Source Type: research
A novel procedure for introducing large sheet-type surgical material with a self-expanding origami structure using a slim trocar (chevron pleats procedure)
ConclusionsCPP is a basic utility procedure for introducing several sheet-type surgical materials into a corporeal cavity with a 5-mm trocar and might help ensure efficient and safe laparoscopic surgery.
Source: Surgical Endoscopy - December 29, 2016 Category: Surgery Source Type: research
Transpalpebral Corrugator Resection: 25-Year Experience, Refinements and Additional Indications
This report highlights the refinements in the transpalpebral corrugator resection that have been implemented over the last 25 years and offers additional indications for its utilization.Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authorswww.springer.com/00266.
Source: Aesthetic Plastic Surgery - February 22, 2017 Category: Cosmetic Surgery Source Type: research
Use of Gelatin Sponge Affects Postoperative Morbidity In Cesarean Section Patients.
CONCLUSIONS Delay in recovery of bowel motility may be due to the local hypersensitivity reaction caused by GS and/or dislocation of this local hemostat. Women who receive gelatin sponge treatment during CS should be monitored closely for the recovery of postoperative intestinal motility.
PMID: 28258978 [PubMed - in process]
Source: Medical Science Monitor - March 5, 2017 Category: Research Tags: Med Sci Monit Source Type: research
Influences of mesoporous zinc-calcium silicate on water absorption, degradability, antibacterial efficacy, hemostatic performances and cell viability to microporous starch based hemostat
In this study, mesoporous zinc-calcium silicate (m-ZCS) was synthesized, and microporous starch (MS) based hemostatic agents of m-ZCS/MS composites for hemorrhage control was fabricated. The results showed that the incorporation of m-ZCS into MS significantly enhanced the water absorption and degradability of the composites, which were dependent on the m-ZCS content. Moreover, the composites with antibacterial property could inhibit the growth of Escherichia coli (E. coli) and the antibacterial ratios increased with the m-ZCS content. The in vitro coagulation evaluation by using activated partial thromboplastin time (APTT)...
Source: Materials Science and Engineering: C - March 17, 2017 Category: Materials Science Source Type: research
Baxter launches next-gen Floseal, Tisseel hemostatic agents
Baxter (NYSE:BAX) today launched next-gen versions of its Floseal and Tisseel hemostatic products, with improved applicability and designs.
The Deerfield, Ill.-based company launched the Floseal full sterile preparation system, designed to be prepared by a single person with fewer steps than previous versions. The newly launched hemostatic has the same clearances as prior versions, the company added.
“Baxter is committed to introducing innovative products designed to improve patient safety and ease of use. We are excited to bring customer-inspired enhancements to our leading hemostat and sealant portfolio that surge...
Source: Mass Device - April 3, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Blood Management Business/Financial News Baxter Source Type: news
